Company: IMNN
Filing Date: 2025-12-31
Form Type: 424B5
Source: 0001493152-25-029712
Chunk: 12

Company: Imunon, Inc.
Filing Date: 2025-12-31
Form: 424B5
Chunk 12
---
 believe we have sufficient funds for our current or future operating plans. To the extent that additional capital is raised through the sale of equity, convertible debt securities or other securities exchangeable for common stock, the issuance of these securities could result in further dilution to our stockholders.

| S-9 |

<div align='center'>DESCRIPTION OF PRE-FUNDED WARRANTS</div>

The following is a summary of the material terms and provisions of the Pre-funded Warrants that are being offered hereby. This summary is subject to and qualified in its entirety by the form of Pre-funded Warrant, which will be filed with the SEC as an exhibit to a Current Report on Form 8-K in connection with this offering and incorporated by reference into the registration statement of which this prospectus supplement and the accompanying prospectus form a part. Prospective investors should carefully review the terms and provisions of the form of Pre-funded Warrant for a complete description of the terms and conditions of the Pre-funded Warrants.

Duration and Exercise Price

Each Pre-funded Warrant has an exercise price of$0.0001 per share. The Pre-funded Warrants will be exercisable immediately following the date of issuance and will not expire. The exercise price and number of shares of common stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting our common stock and the exercise price. ThePre-funded Warrants will be issued separately from the Warrants offered pursuant to this prospectus supplement and may be transferred separately immediately thereafter.

Exercisability

ThePre-funded Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering a duly executed exercise notice accompanied by payment in full for the number of shares of our common stock purchased upon such exercise. Except as agreed with individual holders ofPre-funded Warrants , a holder (together with its affiliates) may not exercise any portion of thePre-funded Warrant to the extent that the holder would own more than 4.99% (or, at the election of the holder, 9.99% of our outstanding shares of common stock immediately after exercise (the “Pre-funded Warrant Beneficial Ownership Limitation”), except that upon at least 61 days’ prior notice from the holder to us, the holder may increase the Pre-funded Warrant Beneficial Ownership Limitation to a percentage not to exceed 9.99%. No fractional shares of common stock will be issued in connection with the exercise of aPre-funded